![](/img/cover-not-exists.png)
Overall Survival (OS) and Progression-Free Survival (PFS) Adjusted for Treatment Crossover in the CALGB/ECOG 100104 (Alliance) Study of Lenalidomide (LEN) Versus Placebo (PBO) Maintenance After Stem Cell Transplant (SCT) for Patients With Newly Diagnosed Multiple Myeloma
McCarthy, Philip, Holstein, Sarah, Jung, Sin-Ho, Cooper, Miranda, Gibson, Craig J., Stadtmauer, Edward, Winograd, Benjamin, Richardson, PaulVolume:
17
Language:
english
Journal:
Clinical Lymphoma Myeloma and Leukemia
DOI:
10.1016/j.clml.2017.03.244
Date:
February, 2017
File:
PDF, 56 KB
english, 2017